Skadden advises Cemex on $650 mln Philippines divestment
Workers are seen at a concrete plant of Mexican cement maker CEMEX in Monterrey, Mexico January 25, 2020. Picture taken January 25, 2020. REUTERS/Daniel Becerril
U.S. law firm Skadden, Arps, Slate, Meagher & Flom has advised Mexico-based multinational building materials company Cemex on the sale of its operations and assets in the Philippines to Dacon Corporation…
CC, Paul Hastings lead on CR Beverages’ HK IPO
Clifford Chance and Jingtian & Gongcheng are advising China Resources Beverages, the beverage division of the state-owned China Resources Enterprise, on its upcoming Hong Kong IPO, which is expected to raise up to $1 billion. Paul Hastings and Zhong Lun Law Firm are acting for the joint sponsors.
Dentons, CMS, Eng advise on $1.25 bln Europe student housing deal
Dentons has advised Singaporean real estate company Mapletree Investments on its one-billion-pound agreement ($1.25 billion) to acquire 8,192 student housing beds across 19 cities in the UK and Germany from Cuscaden Peak Investments, which was represented ed by CMS, Eng and Co, and Carey Olsen.
CAM, JSA advise on NHAI InvIT $870 mln investment top-up
Indian law firm Cyril Amarchand Mangaldas has advised NHAI InvIT (National Highways Infra Trust) (NHIT), a privately listed infrastructure investment trust, on the $740 million issuance of its units by way of an institutional placement to eligible investors.
Haiwen, CC advise on China TCM's $2 bln take-private deal
Sinopharm Group, an investment consortium led by Sinopharm Group, and China Traditional Chinese Medicine Holdings (China TCM) recently announced a take-private deal for the Hong Kong-listed China TCM through a scheme of arrangement.
CC, Davis Polk act on ChaPanda’s $330 mln Hong Kong IPO
Davis Polk & Wardwell and Jingtian & Gongcheng have advised Sichuan Baicha Baidao, a Chinese low-priced tea chain also known as ChaPanda, on its $330 million IPO on the Hong Kong Stock Exchange, with Clifford Chance and King & Wood Mallesons acting for the sponsor CICC and underwriters.
CC, Slaughters advise as HK-listed SciClone goes private for $1.13 bln
Clifford Chance has advised the Hong Kong-listed SciClone Pharmaceuticals on an offer to take it private by healthcare-focused private equity firm GL Capital, with Slaughter and May acting for the buyer’s financial adviser, Capital Corporation Hong Kong Securities (CICC).
Cleary, A&G advise Japan’s Mitsui on $360 mln Ecuador shrimp deal
U.S. law firm Cleary Gottlieb Steen & Hamilton, Singapore’s Allen & Gledhill and two Ecuadorian firms have advised Japanese trading house Mitsui & Co on its $360 million investment in an Ecuadoran shrimp farming company.
Skadden, AMT, MHM, Davis Polk advise on Trial Holding’s $258 mln Japan IPO
Skadden, Arps, Slate, Meagher & Flom and Anderson Mori & Tomotsune have advised Japanese discount-store chain operator Trial Holdings on its $258 million initial public offering on the Tokyo Stock Exchange (TSE), the largest IPO of the year so far.
SAM, HSF guide BAT’s $2.1 bln ITC share sale
Indian law firm Shardul Amarchand Mangaldas & Co and Herbert Smith Freehills have guided British American Tobacco (BAT) on its $2.1 billion strategic divestment in Indian tobacco giant ITC.